- Resource Centers
Marketed by: Dr. Reddy’s Laboratories (Hyderabad, India)
Compared to: Levaquin (Daiichi Sankyo)
Indication: Dr. Reddy’s announced the FDA approval and launch of levofloxacin tablets, a bioequivalent generic version of Levaquin tablets. Levofloxacin is a fluoroquinolone antibacterial used to treat infections of the skin, sinuses, kidneys, bladder, and prostate. It is also indicated for patients with bacterial infections that cause pneumonia and bronchitis, as well as patients who have inhaled anthrax. Like other fluoroquinolones, levofloxacin carries a boxed warning alerting patients of the increased risk of tendinitis and tendon rupture. This risk is higher in patients older than 60 years, those taking corticosteroid drugs, and those with kidney, heart, or lung transplants.
Dosage Form: Tablets: 250, 500, and 750 mg
For More Information: www.drreddys.com
Triamcinolone Acetonide Nasal Spray
Marketed by: Teva Pharmaceuticals (North Wales, PA)
Compared to: Nasacort AQ (sanofiaventis)
Indication: Teva launched triamcinolone acetonide nasal spray, an AB-rated generic version of Nasacort AQ. Triamcinolone acetonide is a corticosteroid indicated for the treatment of nasal symptoms of allergic rhinitis in adults and children 6 years and older. The starting and maximum dose for adults and adolescents 12 years and older is 220 mcg per day. For children aged 6 to 12 years, the starting dose is 110 mcg per day, which may be increased to 220 mcg. Patients should be advised to use the spray on a regular once-daily basis for optimal effect.
Dosage Form: Nasal Spray: 16.5-g bottle containing 120 actuations, each delivering 55 mcg triamcinolone acetonide
For More Information: www.tevausa.com; 888-838-2872
Marketed by: Sandoz (Princeton, NJ)
Compared to: Yasmin (Bayer)
Indication: Sandoz introduced Syeda (drospirenone 3 mg/ethinyl estradiol 0.03 mg) tablets, the fourth product in a line of oral
contraceptives launched by the generic drug maker this year. Equivalent to Bayer’s Yasmin, Syeda is indicated for the prevention of pregnancy in women who choose it as a method of contraception. Patients taking Syeda should be counseled not to smoke, as it increases the risk of serious cardiovascular side effects from oral contraceptives. Syeda is supplied in a dosage regimen identical to that of Yasmin.
Dosage Form: 21 active tablets containing 3 mg drospirenone and 0.03 mg ethinyl estradiol; 7 inactive tablets
For More Information: www.us.sandoz.com; 609-627-8500
Marketed by: Watson Laboratories, a subsidiary of Watson Pharmaceuticals (Parsippany, NJ)
Compared to: Relafen (GlaxoSmithKline)
Indication: Watson Laboratories launched nabumetone tablets, a generic version of GlaxoSmithKline’s Relafen. Nabumetone is a nonsteroidal antinflammatory drug indicated for the relief of signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA). Nabumetone tablets relieve pain, tenderness, swelling, and stiffness caused by OA and RA—diseases that affect more than 28 million US adults, according to the Centers for Disease Control and Prevention. To minimize the risk of gastrointestinal side effects, patients taking nabumetone should receive the lowest possible dose for the shortest possible duration.
Dosage Form: Tablets: 500 and 750 mg
For More Information: www.watson.com